SPARC gains as board to mull fund raising on 14 Jan’26

Attention Investors

Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000. | Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors." | KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary." | ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

- EQUITY
  EQUITY
  PRICE
  
  Gainers & Losers
  
  Advances & Declines
  
  New Highs & Lows
  
  Index Movers
  
  Only Buyers/Sellers
  
  Out/Under Performers
- NEWS
  CORPORATE ACTIONS
  
  Announcements
  
  Book Closure
  
  Board Meetings
  
  Bonus Issues
  
  Rights Issues
  
  De-Listed Shares
  
  Market Turnover
  
  Change of Name
  
  Split of Face Value
- OTHER MARKETS
  FII Investments
  
  MF Investments
  
  ADR Prices
  
  World Indices
  
  Forex
  
  CORPORATE INFO
- VOLUME
  VOLUME
  Value & Volume Toppers
  
  Unusual Volume
  
  Bulk & Block Deals
  
  Sector Watch
- ANALYSIS
  ANALYSIS
  52 Week High Low
  
  Live Indices
  
  Exchange Holidays
  
  Index Constituents
  
  Historical Returns
  
  Circuit Breakers
- IPO
  IPO
  
  Forthcoming Issues
  
  Open Issues
  
  Closed Issues
  
  New Listing
  
  Basis of Allotment
  
  Draft Prospectus
  
  New Issue Monitor
  
  Best Performers
  
  Know IPO's / FAQ's

12 January 2026 00:00:00

Adani Ports

1443.90

(0.57%)

Asian Paints

2896.35

(2.54%)

Axis Bank

1274.25

(0.18%)

Bajaj Finance

951.65

(-0.93%)

Bajaj Finserv

1998.65

(0.30%)

Bharat Electro..

417.65

(-0.29%)

Bharti Airtel

2043.65

(0.81%)

Eternal

285.25

(0.30%)

HCL Technologi..

1668.10

(0.35%)

HDFC Bank

936.65

(-0.22%)

Hind. Unilever

2406.05

(1.36%)

ICICI Bank

1413.15

(0.68%)

Infosys

1595.95

(-1.16%)

Interglobe Avi..

4853.70

(0.19%)

ITC

338.35

(0.37%)

Kotak Mah. Ban..

2133.35

(0.31%)

Larsen & Toubr..

4018.50

(-0.20%)

M & M

3681.15

(0.11%)

Maruti Suzuki

16588.85

(0.53%)

NTPC

337.60

(0.46%)

Power Grid Cor..

258.65

(0.04%)

Reliance Indus..

1483.30

(0.54%)

SBI

1015.05

(1.51%)

Sun Pharma.Ind..

1736.85

(0.40%)

Tata Steel

183.20

(2.75%)

TCS

3235.70

(0.86%)

Tech Mahindra

1585.50

(0.27%)

Titan Company

4231.45

(0.68%)

Trent

4057.15

(2.05%)

UltraTech Cem.

12101.90

(1.26%)

	Equity Analysis

	News Analysis

	Corporate Actions

	Other Market

	Company Profile

Your results on : Equity | News | Hot-Pursuit

SPARC gains as board to mull fund raising on 14 Jan’26	Share Back
(15:45, 12 Jan 2026)
The board will evaluate a proposal to raise funds through a preferential issue, including convertible warrants, to an identified member of the promoter group, subject to receipt of all requisite approvals, consents and permissions, including from the company’s shareholders as well as the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE). Sun Pharma Advanced Research Company is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. The company had reported a consolidated net loss of Rs 75.85 crore in the quarter ended September 2025 as against net loss of Rs 107.33 crore during the previous quarter ended September 2024. Sales declined 38.88% to Rs 7.86 crore in Q2 FY26 over Q2 FY25.
Top